Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province
Authors
Keywords
-
Journal
Vaccines
Volume 9, Issue 6, Pages 628
Publisher
MDPI AG
Online
2021-06-10
DOI
10.3390/vaccines9060628
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Covid-19: Medical community split over vaccine interval policy as WHO recommends six weeks
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- Covid-19 vaccination: What’s the evidence for extending the dosing interval?
- (2021) Gareth Iacobucci et al. BMJ-British Medical Journal
- Predictors of COVID-19 vaccine hesitancy in the UK Household Longitudinal Study
- (2021) Elaine Robertson et al. BRAIN BEHAVIOR AND IMMUNITY
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine hesitancy in the era of COVID-19
- (2021) Gianmarco Troiano et al. PUBLIC HEALTH
- First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021
- (2021) Julianne Gee et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The Changing Acceptance of COVID-19 Vaccination in Different Epidemic Phases in China: A Longitudinal Study
- (2021) Jiahao Wang et al. Vaccines
- Effectiveness of the Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine in preventing SARS-CoV-2 infection among healthcare workers, Treviso province, Veneto region, Italy, 27 December 2020 to 24 March 2021
- (2021) Massimo Fabiani et al. Eurosurveillance
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
- (2021) Eleftheria Vasileiou et al. LANCET
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
- (2021) Victoria Jane Hall et al. LANCET
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
- (2021) Salim S. Abdool Karim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
- (2021) Leonidas Stamatatos et al. SCIENCE
- Covid-19: Risk of cerebral blood clots from disease is 10 times that from vaccination, study finds
- (2021) Ingrid Torjesen BMJ-British Medical Journal
- Delaying the second dose of covid-19 vaccines
- (2021) Dominic Pimenta et al. BMJ-British Medical Journal
- COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021
- (2021) Jennifer L. Kriss et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021
- (2021) Mark G. Thompson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial
- (2021) Daniel Freeman et al. Lancet Public Health
- Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy
- (2021) Chiara Reno et al. Vaccines
- Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2021) Ali Pormohammad et al. Vaccines
- The COVID-19 Vaccine Is Here—Now Who Is Willing to Get It?
- (2021) William D. S. Killgore et al. Vaccines
- Acceptance of COVID-19 Vaccination among Front-Line Health Care Workers: A Nationwide Survey of Emergency Medical Services Personnel from Germany
- (2021) André Nohl et al. Vaccines
- Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens
- (2020) Francesca Bravi et al. PLoS One
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now